| The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries AP Ambrosy, GC Fonarow, J Butler, O Chioncel, SJ Greene, ... Journal of the American College of Cardiology 63 (12), 1123-1133, 2014 | 2366 | 2014 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1334 | 2018 |
| Angiotensin–neprilysin inhibition in acute decompensated heart failure EJ Velazquez, DA Morrow, AD DeVore, CI Duffy, AP Ambrosy, ... New England Journal of Medicine 380 (6), 539-548, 2019 | 1173 | 2019 |
| The Covid-19 pandemic and the incidence of acute myocardial infarction MD Solomon, EJ McNulty, JS Rana, TK Leong, C Lee, SH Sung, ... New England Journal of Medicine 383 (7), 691-693, 2020 | 744 | 2020 |
| Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction … AP Ambrosy, PS Pang, S Khan, MA Konstam, GC Fonarow, B Traver, ... European heart journal 34 (11), 835-843, 2013 | 524 | 2013 |
| Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial AP Ambrosy, M Vaduganathan, MD Huffman, S Khan, MJ Kwasny, ... European journal of heart failure 14 (3), 302-311, 2012 | 228 | 2012 |
| Adverse remodeling and reverse remodeling after myocardial infarction AS Bhatt, AP Ambrosy, EJ Velazquez Current cardiology reports 19, 1-10, 2017 | 224 | 2017 |
| Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril/valsartan or enalapril in the PIONEER-HF trial DA Morrow, EJ Velazquez, AD DeVore, AS Desai, CI Duffy, AP Ambrosy, ... Circulation 139 (19), 2285-2288, 2019 | 180 | 2019 |
| Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial JEA Blair, PS Pang, RW Schrier, M Metra, B Traver, T Cook, U Campia, ... European heart journal 32 (20), 2563-2572, 2011 | 155 | 2011 |
| Haemoconcentration, renal function, and post‐discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial SJ Greene, M Gheorghiade, M Vaduganathan, AP Ambrosy, RJ Mentz, ... European journal of heart failure 15 (12), 1401-1411, 2013 | 143 | 2013 |
| Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial M Vaduganathan, AP Ambrosy, SJ Greene, RJ Mentz, HP Subacius, ... Circulation: Heart Failure 5 (6), 750-758, 2012 | 138 | 2012 |
| Association between aging of the US population and heart disease mortality from 2011 to 2017 S Sidney, AS Go, MG Jaffe, MD Solomon, AP Ambrosy, JS Rana JAMA cardiology 4 (12), 1280-1286, 2019 | 134 | 2019 |
| A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re … M Gheorghiade, PS Pang, AP Ambrosy, G Lan, P Schmidt, G Filippatos, ... Heart failure reviews 17, 485-509, 2012 | 131 | 2012 |
| The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions AP Ambrosy, J Butler, A Ahmed, M Vaduganathan, DJ Van Veldhuisen, ... Journal of the American College of Cardiology 63 (18), 1823-1832, 2014 | 119 | 2014 |
| PIONEER-HF Investigators. Angiotensin-neprilysin inhibition in acute decompensated heart failure EJ Velazquez, DA Morrow, AD DeVore, CI Duffy, AP Ambrosy, ... N Engl J Med 380 (6), 539-548, 2019 | 117 | 2019 |
| Body weight change during and after hospitalization for acute heart failure: patient characteristics, markers of congestion, and outcomes: findings from the ASCEND-HF trial AP Ambrosy, LP Cerbin, PW Armstrong, J Butler, A Coles, AD DeVore, ... JACC: Heart Failure 5 (1), 1-13, 2017 | 110 | 2017 |
| Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of … AP Ambrosy, M Vaduganathan, RJ Mentz, SJ Greene, H Subačius, ... American heart journal 165 (2), 216-225, 2013 | 108 | 2013 |
| The Romanian acute heart failure syndromes (RO-AHFS) registry O Chioncel, D Vinereanu, M Datcu, DD Ionescu, R Capalneanu, I Brukner, ... American heart journal 162 (1), 142-153. e1, 2011 | 90 | 2011 |
| Trends in readmissions and length of stay for patients hospitalized with heart failure in Canada and the United States MD Samsky, AP Ambrosy, E Youngson, L Liang, P Kaul, AF Hernandez, ... JAMA cardiology 4 (5), 444-453, 2019 | 89 | 2019 |
| Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial RJ Mentz, KJ Anstrom, EL Eisenstein, S Sapp, SJ Greene, S Morgan, ... JAMA 329 (3), 214-223, 2023 | 87 | 2023 |
